Skip to main content

Parshall B Lynne's Form 4 filing

Cytokinetics Inc (CYTK) · filed Oct 20, 2021

Accession no.
0001061983-21-000240
Filed
Oct 20, 2021
Trade date
Oct 19, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $369.2K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Parshall B LynneCIK 0001073385Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 19, 2021Common StockMOption exerciseAcquired+1,999$6.84+$13,673.166,999Direct
Oct 19, 2021Common StockSSaleDisposed−1,999$35.73−$71,424.275,000Direct
Oct 19, 2021Common StockMOption exerciseAcquired+8,333$6.60+$54,997.813,333Direct
Oct 19, 2021Common StockSSaleDisposed−8,333$35.73−$297,738.095,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 19, 2021Common StockMOption exerciseDisposed−8,333$0.00$00Direct
Oct 19, 2021Common StockMOption exerciseDisposed−1,999$0.00$02,798Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)